Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,378 | -13,000 | -10,115 | -4,526 | -2,075 |
| Depreciation Amortization | 162 | 637 | 473 | 313 | 155 |
| Accounts receivable | 11 | -25 | 14 | -30 | -118 |
| Accounts payable and accrued liabilities | -2 | 243 | 117 | 19 | 142 |
| Other Working Capital | 62 | 1,894 | 220 | 272 | 148 |
| Other Operating Activity | 393 | 5,052 | 4,618 | 866 | 280 |
| Operating Cash Flow | $-1,752 | $-5,199 | $-4,673 | $-3,086 | $-1,468 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 154 | 154 | 128 | N/A |
| PPE Investments | -38 | -94 | -81 | -13 | 23 |
| Purchase Sale Intangibles | -93 | -377 | -67 | -48 | -28 |
| Other Investing Activity | -93 | -377 | -67 | -48 | -28 |
| Investing Cash Flow | $-131 | $-317 | $6 | $67 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -3 | -3 | -2 | -1 |
| Common Stock Issued | 2,508 | 3,527 | 2,860 | 2,860 | N/A |
| Financing Cash Flow | $2,507 | $3,524 | $2,857 | $2,858 | $-1 |
| Exchange Rate Effect | 2 | -6 | -8 | -9 | 1 |
| Beginning Cash Position | 1,198 | 3,196 | 3,196 | 3,196 | 3,196 |
| End Cash Position | 1,824 | 1,198 | 1,378 | 3,026 | 1,723 |
| Net Cash Flow | $626 | $-1,998 | $-1,818 | $-170 | $-1,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,752 | -5,199 | -4,673 | -3,086 | -1,468 |
| Capital Expenditure | -38 | -138 | -123 | -55 | -20 |
| Free Cash Flow | -1,790 | -5,337 | -4,796 | -3,141 | -1,488 |